Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
Recruiting
Observational Study
Biliary Atresia
Prognosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Children's Hospital of Fudan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To investigate the role of preoperative serum FGF19 level in the prognosis of biliary atresia.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Samples diagnosed as biliary atresia in Children's Hospital of Fudan University
* Samples with one-year follow-up records after surgery
* Samples with a record of serum total bilirubin levels three months after surgery
* Samples with preoperative serum left（volume \> 500ul)
E…
Contacts